EVGN vs. CGA, SNES, NITO, SVFD, UAN, MBII, AVD, NTR, CF, and MOS
Should you be buying Evogene stock or one of its competitors? The main competitors of Evogene include China Green Agriculture (CGA), SenesTech (SNES), N2OFF (NITO), Save Foods (SVFD), CVR Partners (UAN), Marrone Bio Innovations (MBII), American Vanguard (AVD), Nutrien (NTR), CF Industries (CF), and Mosaic (MOS).
Evogene (NASDAQ:EVGN) and China Green Agriculture (NYSE:CGA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability, institutional ownership, dividends and risk.
Evogene has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, China Green Agriculture has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500.
China Green Agriculture has higher revenue and earnings than Evogene. Evogene is trading at a lower price-to-earnings ratio than China Green Agriculture, indicating that it is currently the more affordable of the two stocks.
China Green Agriculture has a net margin of -27.43% compared to Evogene's net margin of -233.66%. China Green Agriculture's return on equity of -22.74% beat Evogene's return on equity.
10.4% of Evogene shares are owned by institutional investors. Comparatively, 0.1% of China Green Agriculture shares are owned by institutional investors. 7.4% of Evogene shares are owned by company insiders. Comparatively, 34.3% of China Green Agriculture shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Evogene received 26 more outperform votes than China Green Agriculture when rated by MarketBeat users. Likewise, 59.19% of users gave Evogene an outperform vote while only 55.14% of users gave China Green Agriculture an outperform vote.
Evogene currently has a consensus target price of $3.62, indicating a potential upside of 420.46%. Given Evogene's higher probable upside, equities research analysts plainly believe Evogene is more favorable than China Green Agriculture.
In the previous week, Evogene's average media sentiment score of 0.00 equaled China Green Agriculture'saverage media sentiment score.
Summary
Evogene beats China Green Agriculture on 8 of the 15 factors compared between the two stocks.
Get Evogene News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
